Replies to post #305791 on Avid Bioservices Inc (CDMO)

[north40000]

BMY sues nearly everyone with I-O FDA-approved therapy, the latest today:

https://www.bizjournals.com/sanfrancisco/news/2017/07/26/genentech-cancer-immunotherapy-bms-bmy-pd-1-pd-l1.html

The long shots continue:

"Those therapies have seen response rates of 20 percent or greater in the short term, but researchers have keyed in potential combination therapies to accelerate those rates and extend the time cancers are held back."

Once again:

"PPHM's point to each of above entities is: none of combos tried so far give good, economically favorable, increased RRRS values, PFS values, OS or mOS values for enough patients. What else are you going to try in a combo trial?

Brekken's mice died of old age. Dr Wolchok/MSKCC knows that, and has the ears and eyes of all.

And suddenly PPHM is $ 0.05--0.07 + today real time

[geocappy1]

Imminent? Could be now or never for current guys.What will they do? What will they do?

[cheynew]

No offense James, but none of your "imminent" or other predictions have ever materialized.